Lurasidone continuation in real-world clinical cases in Japan: retrospective study of factors associated with six-month persistence
This is the first known study to evaluate real-world lurasidone persistence in patients in Japan. The findings indicate that both pharmacodynamic compatibility and early-phase treatment can enhance persistence. The insights obtained underscore the importance of individualized treatment planning, though require further validation by use of prospective, multi-center studies.
Authors
- Yasuhiro Mori (ORCID: https://orcid.org/0000-0002-5066-2390)
- Takahide Fukatsu (ORCID: https://orcid.org/0000-0001-6019-030X)
- Mihoko Kawai (ORCID: https://orcid.org/0000-0002-0965-5092)
- Kohei Fujita (ORCID: https://orcid.org/0000-0002-8551-9324)
- Takaaki Yoshimoto (ORCID: https://orcid.org/0000-0003-1438-5776)
- Makoto Nishihara (ORCID: https://orcid.org/0000-0003-1719-6495)
- Jun Miyata (ORCID: https://orcid.org/0000-0002-3189-1702)
- Yuko Sugimoto
- Ryosuke Aratake
Institutions
- Aichi Medical University (JP)
- Nagoya Central Hospital (JP)
Publication Details
- Journal
- Annals of General Psychiatry
- Published
- 2026-02-15
- DOI
- https://doi.org/10.1186/s12991-026-00640-x
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00